Evidence map›Paper›PMID 41971050›Full record

ArticleBrain communications2026

Insomnia, sleep duration and incident Parkinson's disease in the Finnish population cohort.

Sonja Sulkava, Katri Kantojärvi, Jari Haukka, Tiina Paunio

Abstract read
In one paragraph

Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sonja SulkavaDepartment of Psychiatry and SleepWell Research Programme, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki 00260, Finland.ORCID https://orcid.org/0000-0002-6938-2620
Katri KantojärviDepartment of Psychiatry and SleepWell Research Programme, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki 00260, Finland.
Jari HaukkaDepartment of Public Health, University of Helsinki, Helsinki 00290, Finland.ORCID https://orcid.org/0000-0003-1450-6208
Tiina PaunioDepartment of Psychiatry and SleepWell Research Programme, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki 00260, Finland.ORCID https://orcid.org/0000-0002-5560-0666

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sleep problems are common in Parkinson's disease. Several lines of research have linked insufficient sleep to neurodegenerative processes, raising the possibility that sleep disturbances may serve as aetiological risk factors for neurodegenerative diseases. However, most cohort studies on sleep traits and Parkinson's disease have been too short to disentangle risk factors from prodromal symptoms. This study investigated the association of insomnia and sleep duration with incident Parkinson's disease in a Finnish cohort with long follow-up and modelling for the competing risk of death. The study included 73 281 Parkinson's disease-free participants with a mean age of 45.7 (12.3) years from the National FINRISK Study surveys conducted every 5 years from 1972 to 2012. Insomnia (never, sometimes and often) and night-time sleep duration (<7 h, 7-8 h, >8 h) were self-reported at baseline and linked with health register data on incident Parkinson's disease. We applied both a cause-specific hazard model (Poisson) and a subdistribution hazard model (Fine-Gray) accounting for the competing risk of death. Additionally, we examined associations between polygenic risk scores for the sleep traits and Parkinson's disease. During 1 806 843 person-years of follow-up (mean 24.6 ± 12.4 years), 2679 participants developed Parkinson's disease. The cause-specific hazard model showed an association of insomnia reported as sometimes (IRR 1.14, 95% CI 1.05-1.24) and often (IRR 1.54, 95% CI 1.35-1.75) with Parkinson's disease, and a subdistribution hazard model showed an association of insomnia often (IRR 1.26, 95% CI 1.11-1.43). In sensitivity analyses excluding individuals with <20 years of follow-up, the association for insomnia symptoms often remained (IRR 1.37, 95% CI 1.13-1.66). Neither self-reported short nor long sleep duration was associated with Parkinson's disease. Accordingly, polygenic risk score for insomnia (IRR 1.13, 95% CI 1.05-1.23) but not for short or long sleep was associated with incident Parkinson's disease. In this long-term cohort study, both self-reported insomnia and genetic liability to insomnia were associated with an increased risk of incident Parkinson's disease, suggesting insomnia is a potential risk factor rather than solely a prodromal symptom. However, the attenuated association of insomnia with the cumulative incidence of Parkinson's disease in the subdistribution hazard model accounting for the competing risk of death suggests a modest real-life effect.

Indexed as

competing risksgenetic risk scoreParkinson’s diseaseprospective studysleep disturbance

Identifiers

PMID41971050
PMCPMC13061589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.